The reversal of experimental porphyria and the prevention of induction of hepatic mixed-function oxidase by acetate.
D000624:5-Aminolevulinate Synthetase / Q000096:biosynthesis; D000085:Acetates / Q000494:pharmacology* / Q000627:therapeutic use; D000622:Aminolevulinic Acid / Q000652:urine; D000818:Animals; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D003579:Cytochrome Reductases / Q000096:biosynthesis; D003574:Cytochrome c Group; D003998:Dicarboxylic Acids; D004790:Enzyme Induction / Q000187:drug effects; D008099:Liver / Q000187:drug effects / Q000201:enzymology*; D008297:Male; D008862:Microsomes, Liver / Q000187:drug effects / Q000201:enzymology; D006899:Mixed Function Oxygenases / Q000096:biosynthesis*; D010088:Oxidoreductases / Q000096:biosynthesis*; D010634:Phenobarbital / Q000494:pharmacology; D011162:Porphobilinogen / Q000652:urine; D011164:Porphyrias / Q000139:chemically induced / Q000188:drug therapy / Q000201:enzymology* / Q000652:urine; D011166:Porphyrins / Q000652:urine; D011725:Pyridines; D051381:Rats; D013053:Spectrophotometry; D013424:Sulfanilamides / Q000494:pharmacology
D000085:Acetates; D003574:Cytochrome c Group; D003998:Dicarboxylic Acids; D011166:Porphyrins; D011725:Pyridines; D013424:Sulfanilamides; D011162:Porphobilinogen; D000622:Aminolevulinic Acid; D003577:Cytochrome P-450 Enzyme System; D006899:Mixed Function Oxygenases; D010088:Oxidoreductases; D003579:Cytochrome Reductases; D000624:5-Aminolevulinate Synthetase; D010634:Phenobarbital